Public COA audit
NAD+ · Nicotinamide Adenine Dinucleotide
Audited July 29, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 92
- Confidence
- 88%
- Panels
- 2/7
- Purity (printed)
- 99.45%
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- APR-5787466
- Identity method
- UPLC/MS (Ultra High Performance Liquid Chromatography with Mass Spectrometry)
- Sample date
- 2026-03-17
- Issue date
- 2026-03-22
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
2 of 7 present · 2 passed · 0 failed · 0 reported · 5 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
NAD+ confirmed
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.45%
Heavy metals
Not on this COA
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Microbial
Not on this COA
Bioburden / microbial limits testing.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Endotoxin
Not on this COA · core
LAL or chromogenic endotoxin assay.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Sterility
Not on this COA
Sterility testing where applicable.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Residual solvent / water
Not on this COA
Residual solvents or water content limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing
Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High purity confirmed
UPLC analysis shows 99.45% purity, which is excellent for research-grade NAD+ and consistent with lyophilized powder specifications
Identity confirmed by orthogonal methods
Both UPLC chromatogram and MS spectrum provided, showing expected molecular ion peaks consistent with NAD+ (C21H27N7O14P2, MW ~663 g/mol)
Complete batch traceability
Lot number APR-5787466 clearly stated with client name (American peptide research) and compound details
Appropriate timeline
Received 2026-03-17, analyzed 2026-03-22 (5-day turnaround is reasonable for analytical testing)
Professional presentation
Document includes lab branding, analyst signature (Aleksey Yevtodiyenko PhD), contact information, and QR code for validation
Limited testing scope
Only identity and purity panels performed. No heavy metals, microbial, endotoxin, sterility, or residual solvent testing. This is common for basic analytical COAs but limits safety assurance
Clear data presentation
Includes specification vs. result comparison (>98% spec, 99.45% result), chromatogram, mass spectrum, and PubChem CID reference (925)
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.